What Are Selumetinib (Koselugo) Side Effects in NF1?

Starting a MEK inhibitor like selumetinib (Koselugo) can be a major milestone for a child with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas. While these medications can effectively shrink tumors, they also come with a specific side effect profile ^[1][2]. Fortunately, most side effects are manageable, especially if caught early ^[3][4].

Knowing what to expect and how your child’s care team will monitor them allows you to be an active, empowered partner in their treatment.

Common Daily Side Effects

Many children taking selumetinib experience day-to-day side effects affecting their skin, stomach, and energy levels. These are usually manageable without stopping the medication completely.

• Skin and Nail Changes: Dermatological issues are very common. Your child might develop an acneiform rash (which looks like acne but isn’t), extremely dry skin (xerosis), or paronychia (painful inflammation where the skin meets the nail) ^[5][6]. Your care team may prescribe specific creams, gentle skincare routines, or oral antibiotics to manage these issues ^[7]. Note: Because selumetinib and some antibiotics can make your child’s skin more sensitive to the sun, aggressive sun protection (hats, sunscreen) is highly recommended.
• Stomach Upset and Dosing Routine: Gastrointestinal symptoms like diarrhea, nausea, and mouth sores (stomatitis) can occur ^[8][9]. This is sometimes complicated by the strict dosing schedule: selumetinib is usually taken twice daily and must be swallowed whole on an empty stomach (typically 2 hours after a meal and 1 hour before the next) ^[2].
• Fatigue and Swelling: It is common for children to feel more tired than usual. You might also notice edema, which is mild swelling, often around the eyes or in the arms and legs ^[5].

“Invisible” Side Effects and Scheduled Monitoring

Some of the most important side effects happen inside the body and do not cause obvious symptoms right away. Because of this, your child will undergo strict, scheduled testing to catch these issues early ^[2]. This monitoring is usually most frequent during the first few months of treatment ^[4].

Heart Changes (Cardiotoxicity)

Selumetinib can cause a decrease in the heart’s pumping strength, known as a reduction in left ventricular ejection fraction (LVEF) ^[10][11]. This is usually asymptomatic, meaning your child won’t feel it.

• How it is monitored: Your child will have regular echocardiograms (ECHOs) to ensure their heart is pumping normally. They may also have EKGs to monitor the heart’s electrical rhythm.
• How it is managed: If the pumping strength drops, the doctor may lower the medication dose or pause it temporarily to allow the heart to recover ^[12].

Eye Issues (Ocular Toxicity)

MEK inhibitors carry a risk of eye problems, including dry eyes and MEK inhibitor-associated retinopathy (MEKAR) ^[13]. MEKAR can involve a temporary buildup of fluid under the retina ^[14].

• How it is monitored: Comprehensive ophthalmologic (eye) exams are required before starting the drug and at regular intervals during treatment ^[15].
• How it is managed: Many eye issues are mild and resolve on their own ^[16]. Dry eyes can be treated with eye drops, but severe vision changes might require pausing selumetinib ^[17].

Muscle Enzyme Spikes

Routine bloodwork often reveals elevated levels of creatine phosphokinase (CPK), an enzyme found in the muscles ^[18][19]. A high CPK level indicates muscle irritation, but children usually have no symptoms of muscle pain or weakness ^[20].

• How it is monitored: Regular blood draws to check CPK levels.
• How it is managed: If levels climb too high, a temporary break from the medication or a dose reduction is usually enough to bring the numbers down safely ^[12].

How Are Side Effects Managed?

Management focuses on balancing the benefits of shrinking the tumor against the toll the side effects take on your child’s quality of life ^[3]. The first month of treatment is critical for establishing a baseline and catching issues early ^[4].

If your child experiences bothersome side effects, their oncologist has a few tools:

1. Supportive Care: Using other medications (like anti-diarrhea drugs, antibiotics, or skin creams) to treat the side effect while continuing selumetinib ^[7].
2. Dose Reduction: Lowering the daily dose of selumetinib.
3. Treatment Interruption: Pausing the medication for a short period to let the body recover, then restarting it (often at a lower dose) ^[12][21].

You won’t be managing this alone. This therapy requires a multidisciplinary team, meaning your oncologist will work closely with dermatologists, cardiologists, and eye doctors ^[3][20].

When to Call the Doctor Immediately

Do not wait for your next scheduled appointment if your child experiences any of the following “red flag” symptoms:

• Sudden Vision Changes: Any complaints of blurry vision, “floaters,” or partial vision loss.
• Signs of Dehydration: If diarrhea or vomiting is severe and your child cannot keep fluids down, or shows signs of dehydration (dry mouth, no tears when crying, decreased urination).
• Severe Muscle Pain: Unexplained, severe muscle aches or weakness (which could indicate a dangerous spike in CPK levels).
• Shortness of Breath: Difficulty breathing or sudden extreme fatigue, which could be related to heart changes.

(Note: There have also been rare reports of impaired bone healing or fractures in children on selumetinib, particularly around the time of orthopedic surgeries ^[22].)